No Data
No Data
No Data
No Data
No Data
Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer
FRANKLIN, Tenn., April 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement technology company, today announced the
GlobeNewswire16:05 ET
Are Investors Undervaluing Omnicell, Inc. (NASDAQ:OMCL) By 34%?
Key Insights The projected fair value for Omnicell is US$39.89 based on 2 Stage Free Cash Flow to Equity Current share price of US$26.27 suggests Omnicell is potentially 34% undervalued The US$33
Simply Wall StApr 18 07:30 ET
Omnicell (OMCL) Receives a Buy From Craig-Hallum
TipRanksApr 17 08:55 ET
Omnicell's Strategic Shift to Recurring Revenue: A Cautious Hold Amidst Transformation Uncertainty
TipRanksApr 17 05:07 ET
Omnicell Announces XT Amplify, A Multi-Year Innovation Program That Is Intended To Maximize Value For Hospitals, Health Systems, And Post-Acute Care Facilities That Have Invested In Omnicell's XT Automated Dispensing System
Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing SystemOmnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a leader in transforming the pharmac
BenzingaApr 16 16:14 ET
Omnicell Announces XT Amplify
Omnicell, Inc. (Nasdaq:OMCL) ("Omnicell" or the "Company"), a leader in transforming the pharmacy care delivery model, today announced XT Amplify, a multi-year innovation program that is intended to maximize value for hospitals, health systems, and post-acute care facilities that have invested in Omnicell's XT Automated Dispensing System while also seeking to drive enhanced clinical and operational outcomes at the points of care and within pharmacies.
BusinesswireApr 16 16:01 ET
No Data
No Data